Guise TA, Wysolmerski JJ, Cancer-Associated Hypercalcemia. Solomon CG, editors. N Engl J Med. 2022;386(15):1443–51. https://doi.org/10.1056/NEJMcp2113128

Gastanaga VM, Schwartzberg LS, Jain RK, Pirolli M, Quach D, Quigley JM, et al. Prevalence of hypercalcemia among cancer patients in the united States. Cancer Med. 2016;5(8):2091–100. https://doi.org/10.1002/cam4.749.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goltzman D. Pathophysiology of hypercalcemia. Endocrinology and metabolism clinics of North America. 2021;50(4):591–607. https://doi.org/10.1016/j.ecl.2021.07.008

Sadiq NM, Naganathan S, Badireddy M. Hypercalcemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2024 Jan 8]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430714/

Tebben PJ, Kumar R. CHAPTER 66 - The Hormonal Regulation of Calcium Metabolism. In: Alpern RJ, Hebert SC, editors. Seldin and Giebisch’s The Kidney (Fourth Edition). San Diego: Academic Press; 2008 [cited 2024 Jan 8]. pp. 1891–909. Available from: https://www.sciencedirect.com/science/article/pii/B9780120884889500693

Previously 7 Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990;50(19):6130–8.

Google Scholar 

Previously 8, Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and Non-Hodgkin’s lymphomas. Blood. 1993;82(5):1383–94.

Article  Google Scholar 

Previously T, Hiraga T. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochemical and Biophysical Research Communications. 2005;328(3):679–87. https://doi.org/10.1016/j.bbrc.2004.11.070

Akhtar M, Haider A, Rashid S, Al-Nabet ADMH. Paget’s “seed and soil” theory of cancer metastasis: an idea whose time has come. Adv Anat Pathol. 2019;26(1):69–74. https://doi.org/10.1097/PAP.0000000000000219

Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55(1):61–6. https://doi.org/10.1038/bjc.1987.13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–93. https://doi.org/10.1038/nrc867.

Article  CAS  PubMed  Google Scholar 

Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, et al. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res. 1990;50(23):7710–6.

CAS  PubMed  Google Scholar 

Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res. 1991;51(11):3059–61.

CAS  PubMed  Google Scholar 

Bryden AAG, Hoyland JA, Freemont AJ, Clarke NW, George NJR. Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases. Br J Cancer. 2002;86(3):322–5. https://doi.org/10.1038/sj.bjc.6600115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miki T, Yano S, Hanibuchi M, Sone S. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol Res. 2000;12(5):209–17. https://doi.org/10.3727/096504001108747701.

Article  CAS  PubMed  Google Scholar 

Leibbrandt A, Penninger JM. RANKL/RANK as Key Factors for Osteoclast Development and Bone Loss in Arthropathies. In: López-Larrea C, Díaz-Peña R, editors. Molecular Mechanisms of Spondyloarthropathies. New York, NY: Springer; 2009 [cited 2024 Jan 8]. pp. 100–13. (Advances in Experimental Medicine and Biology). Available from: https://doi.org/10.1007/978-1-4419-0298-6_7

Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest. 1996;98(7):1544–9. https://doi.org/10.1172/JCI118947.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer. 1983;51(5):918–24. https://doi.org/10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j.

Article  CAS  PubMed  Google Scholar 

Zhang QX, Borg A, Wolf DM, Oesterreich S, Fuqua SA. An Estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res. 1997;57(7):1244–9.

CAS  PubMed  Google Scholar 

De Larco JE, Wuertz BRK, Rosner KA, Erickson SA, Gamache DE, Manivel JC, et al. A potential role for Interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol. 2001;158(2):639–46. https://doi.org/10.1016/S0002-9440(10)64005-9.

Article  PubMed  PubMed Central  Google Scholar 

Downey SE, Hoyland J, Freemont AJ, Knox F, Walls J, Bundred NJ. Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue. J Pathol. 1997;183(2):212–7. https://doi.org/10.1002/(SICI)1096-9896(199710)183:2<212::AID-PATH920>3.0.CO;2-O.

Article  CAS  PubMed  Google Scholar 

Hu MI. Hypercalcemia of malignancy. Endocrinol Metab Clin North Am. 2021;50(4):721–8. https://doi.org/10.1016/j.ecl.2021.07.003.

Article  PubMed  Google Scholar 

Yoshimoto K, Yamasaki R, Sakai H, Tezuka U, Takahashi M, Iizuka M, et al. Ectopic production of parathyroid hormone by small cell lung Cancer in a patient with hypercalcemia. J Clin Endocrinol Metab. 1989;68(5):976–81. https://doi.org/10.1210/jcem-68-5-976.

Article  CAS  PubMed  Google Scholar 

Uchimura K, Mokuno T, Nagasaka A, Hayakawa N, Kato T, Yamazaki N, et al. Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels. Metabolism. 2002;51(7):871–5. https://doi.org/10.1053/meta.2002.33341.

Article  CAS  PubMed  Google Scholar 

Nussbaum SR, Gaz RD, Arnold A. Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med. 1990;323(19):1324–8. https://doi.org/10.1056/NEJM199011083231907.

Article  CAS  PubMed  Google Scholar 

Buller R, Taylor K, Burg AC, Berman ML, DiSaia PJ. Paraneoplastic hypercalcemia associated with adenosquamous carcinoma of the endometrium. Gynecol Oncol. 1991;40(1):95–8. https://doi.org/10.1016/0090-8258(91)90095-m.

Article  CAS  PubMed  Google Scholar 

Iguchi H, Miyagi C, Tomita K, Kawauchi S, Nozuka Y, Tsuneyoshi M, et al. Hypercalcemia caused by ectopic production of parathyroid hormone in a patient with papillary adenocarcinoma of the thyroid gland. J Clin Endocrinol Metabolism. 1998;83(8):2653–7. https://doi.org/10.1210/jcem.83.8.5025.

Article  CAS  Google Scholar 

Crowley R, Gittoes N. How to approach hypercalcaemia. Clin Med (Lond). 2013;13(3):287–90. https://doi.org/10.7861/clinmedicine.13-3-287.

Article  PubMed  Google Scholar 

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. https://doi.org/10.1210/jc.2011-0385.

Article  CAS  PubMed  Google Scholar 

Khairallah W, Fawaz A, Brown EM, El-Hajj Fuleihan G. Hypercalcemia and diabetes insipidus in a patient previously treated with lithium. Nat Rev Nephrol. 2007;3(7):397–404. https://doi.org/10.1038/ncpneph0525

Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, et al. Bone health in cancer: ESMO Clinical Practice Guidelines. Annals of Oncology. 2020;31(12):1650–63. https://doi.org/10.1016/j.annonc.2020.07.019.

Walker MD, Shane E, Hypercalcemia. Rev JAMA. 2022;328(16):1624–36. https://doi.org/10.1001/jama.2022.18331.

Hosking DJ, Cowley A, Bucknall CA. Rehydration in the treatment of severe hypercalcaemia. QJM: Int J Med. 1981;50(4):473–81.

CAS  Google Scholar 

Gucalp R, Theriault R, Gill I, Madajewicz S, Chapman R, Navari R, et al. Treatment of Cancer-Associated Hypercalcemia: Double-blind Comparison of Rapid and Slow Intravenous Infusion Regimens of Pamidronate Disodium and Saline Alone. Archives of Internal Medicine. 1994;154(17):1935–44. https://doi.org/10.1001/archinte.154.17.1935.

El-Hajj Fuleihan G, Clines GA, Hu MI, Marcocci C, Murad MH, Piggott T, et al. Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2023 Feb 15;108(3):507–28. Doi: 10.1210/clinem/dgac621.

Grieff M, Bushinsky DA. Diuretics and disorders of calcium homeostasis. In: Sterns SH, editor. Seminars in nephrology. Volume 31. Elsevier; 2011.

Suki WN, Yium JJ, Von Minden M, Saller-Hebert C, Eknoyan G, Martinez-Maldonado M. Acute treatment of hypercalcemia with Furosemide. N Engl J Med. 1970;283(16):836–40. https://doi.org/10.1056/NEJM197010152831603.

Article  CAS  PubMed  Google Scholar 

Silva OL, Becker KL. Salmon calcitonin in the treatment of hypercalcemia. Arch Intern Med. 1973;132(3):337–9.

Article  CAS  PubMed  Google Scholar 

Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet. 1985;2(8461):907–10. https://doi.org/10.1016/s0140-6736(85)90848-7.

Article  CAS  PubMed